Drug trial shows promise for improving alertness in shift workers
藥物試驗顯示有望改善輪班工作者的警覺性
For millions of people working nights, life is a constant battle against their natural circadian rhythm.
對於數百萬夜間工作者而言，生活是不斷與自身生理時鐘對抗的戰場。
Shift Work Sleep Disorder (SWSD) impacts up to 40% of these workers, causing extreme daytime sleepiness and insomnia.
輪班工作睡眠障礙影響了這些工作者中高達40%的人，導致極度的日間嗜睡與失眠。
While stimulants like caffeine or prescription modafinil are standard, scientists are now testing new, targeted drugs designed to promote alertness more safely by avoiding traditional pathways that risk dependency.
雖然咖啡因或處方藥物莫達非尼等興奮劑是標準療法，科學家目前正在測試新型的標靶藥物，旨在透過避開有依賴風險的傳統路徑，更安全地提升警覺性。
Managing SWSD effectively requires a holistic approach, including strategic napping, controlled light therapy, and rigorous sleep hygiene.
有效地管理SWSD需要全盤的策略，包括策略性的小睡、受控的光照療法以及嚴格的睡眠衛生。
As research moves toward personalized, chronotype-based medicine, the hope is to reduce both the cognitive decline and the safety risks associated with non-traditional schedules.
隨著研究朝向個人化、基於生理時鐘類型的醫學發展，期望能降低與非傳統時間表相關的認知退化與安全風險。
